These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23553928)

  • 1. An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutations.
    Ayturk UM; Jacobsen CM; Christodoulou DC; Gorham J; Seidman JG; Seidman CE; Robling AG; Warman ML
    J Bone Miner Res; 2013 Oct; 28(10):2081-93. PubMed ID: 23553928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner.
    Niziolek PJ; Warman ML; Robling AG
    Bone; 2012 Sep; 51(3):459-65. PubMed ID: 22750014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the LRP5 pathway improves bone properties in a mouse model of osteogenesis imperfecta.
    Jacobsen CM; Barber LA; Ayturk UM; Roberts HJ; Deal LE; Schwartz MA; Weis M; Eyre D; Zurakowski D; Robling AG; Warman ML
    J Bone Miner Res; 2014 Oct; 29(10):2297-306. PubMed ID: 24677211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
    Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
    Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.
    Niziolek PJ; MacDonald BT; Kedlaya R; Zhang M; Bellido T; He X; Warman ML; Robling AG
    J Bone Miner Res; 2015 Oct; 30(10):1822-30. PubMed ID: 25808845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.
    Niziolek PJ; Bullock W; Warman ML; Robling AG
    PLoS One; 2015; 10(11):e0140775. PubMed ID: 26554834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it.
    Saxon LK; Jackson BF; Sugiyama T; Lanyon LE; Price JS
    Bone; 2011 Aug; 49(2):184-93. PubMed ID: 21419885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.
    Niziolek PJ; Farmer TL; Cui Y; Turner CH; Warman ML; Robling AG
    Bone; 2011 Nov; 49(5):1010-9. PubMed ID: 21855668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-Function Lrp5 Mutation Improves Bone Mass and Strength and Delays Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes.
    Leanza G; Fontana F; Lee SY; Remedi MS; Schott C; Ferron M; Hamilton-Hall M; Alippe Y; Strollo R; Napoli N; Civitelli R
    J Bone Miner Res; 2021 Jul; 36(7):1403-1415. PubMed ID: 33831261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
    Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
    J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
    Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
    Bone; 2024 Oct; 187():117172. PubMed ID: 38909879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous deletion of LRP5 gene in mice alters profile of immune cells and modulates differentiation of osteoblasts.
    Li L; Wang Y; Zhang N; Zhang Y; Lin J; Qiu X; Gui Y; Wang F; Li D; Wang L
    Biosci Trends; 2018 Jul; 12(3):266-274. PubMed ID: 29899194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.
    Foer D; Zhu M; Cardone RL; Simpson C; Sullivan R; Nemiroff S; Lee G; Kibbey RG; Petersen KF; Insogna KL
    Osteoporos Int; 2017 Jun; 28(6):2011-2017. PubMed ID: 28283687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis.
    Lodewyckx L; Luyten FP; Lories RJ
    Rheumatology (Oxford); 2012 Nov; 51(11):1973-8. PubMed ID: 22850184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.
    Turkkahraman H; Flanagan S; Zhu T; Bellido TM; Yuan X
    J Periodontal Res; 2023 Aug; 58(4):723-732. PubMed ID: 37128744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
    Rickels MR; Zhang X; Mumm S; Whyte MP
    J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Overexpression of Lrp5 on the Temporomandibular Joint.
    Utreja A; Motevasel H; Bain C; Holland R; Robling A
    Cartilage; 2021 Dec; 13(2_suppl):419S-426S. PubMed ID: 33124433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.